Absorption, Distribution, Metabolism, and Excretion of Capmatinib (INC280) in Healthy Male Volunteers and In Vitro Aldehyde Oxidase Phenotyping of the Major Metabolite-Reference-Cited by-同舟云学术

Absorption, Distribution, Metabolism, and Excretion of Capmatinib (INC280) in Healthy Male Volunteers and In Vitro Aldehyde Oxidase Phenotyping of the Major Metabolite

Published:2020-07-14 Issue:10 Volume:48 Page:873-885
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Glaenzel Ulrike,Jin Yi,Hansen Regine,Schroer Kirsten,Rahmanzadeh Gholamreza,Pfaar Ulrike,Jaap van Lier Jan,Borell Hubert,Meissner Axel,Camenisch Gian,Zhao Sylvia

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference29 articles.

1. MET Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression

2. Capmatinib (INC280) Is Active Against Models of Non–Small Cell Lung Cancer and Other Cancer Types with Defined Mechanisms of MET Activation

3. IncreasedMETGene Copy Number Negatively Affects Survival of Surgically Resected Non–Small-Cell Lung Cancer Patients

4. Optimization of routine testing for MET exon 14 splice site mutations in NSCLC patients;Descarpentries;J Thorac Oncol,2018

5. High MET Receptor Expression But Not Gene Amplification in ALK 2p23 Rearrangement Positive Non–Small-Cell Lung Cancer

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel disposable ultrasensitive sensor based on nanosized ceria uniformly loaded carbon nanofiber nanoceramic film wrapped on pencil graphite rods for electrocatalytic monitoring of a tyrosine kinase inhibitor capmatinib;Talanta;2024-11

2. Development and validation of an LC-MSMS method for the quantitation of pacritinib; application of kinetics in rabbits;Journal of Pharmacological and Toxicological Methods;2024-09

3. Use of Structural Alerts for Reactive Metabolites in the Application SpotRM;Chemical Research in Toxicology;2024-08-01

4. The Drug-Drug Interaction between Erlotinib and OSI-930 Is Mediated through Aldehyde Oxidase Inhibition;Drug Metabolism and Disposition;2024-06-18

5. Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy;Molecular Cancer;2024-06-07